Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
Agreement offers exclusive rights to commercialize six products in key areas of anti-infectives and oncology. Products from Adalvo slated for near- to mid-term launches, with four out of six... | May 4, 2023